INTRODUCTION
============

Leukemia makes up about one third of all malignancies in the 0-14 year old age group. The most common subtype, acute lymphoblastic leukemia (ALL), represents about 80.0% of these cases. ^[@r57]^ The incidence rate of ALL was estimated as 35.2 per million children aged under 15 in Brazil, and children under five are the most affected.^[@r60]^

Potential risk factors for childhood leukemia (CL) are conflicting. Exposure to ionizing radiation, commonly accepted as a cause of leukemia, does not explain all cases of leukemia in children. ^[@r05]^ The etiology of CL has a multifactorial character. Leukemic cells that carry genetic alterations arise mainly before birth. Translocation between chromosomes 12 and 21 causes fusion of the TEL and AML1 gene; producing aberrant proteins that inhibit gene activity and change the capacity for self-renewal and differentiation of hematopoietic stem cells; this change represents the most common structural genetic abnormality in children with leukemia. ^[@r45],[@r74]^ About 1.0% of healthy newborns have this translocation and one leukemic clone generated in the uterus, however, they do not develop disease. ^[@r45]^ This fact and the low correlation between identical twin ALL (about 5,0% in infants 2-6 years) suggests that the disease probably begins in uterus, but a postnatal event is required for it to develop; this is known as a \"two hit model\". ^[@r16],[@r17]^ Studies have tested whether infections may be involved in the etiology of CL. Three main hypothesis can explain the impact infections have on the disease development.

Smith ^[@r76]^ suggested that infection during pregnancy allows the infectious agent to be transmitted to the fetus and cause genetic instability, which leads to increased risk of developing c-ALL (B-cell precursor of common ALL) up to five years of age. This proposal would explain the peak occurrence of ALL in the 2-5 year old age group.

The hypothesis of \"delayed infection\", proposed by Greaves^[@r17],[@r19]^ suggests that the occurrence of common infections early in life may play a protective role against ALL (especially subtype c-ALL). Whereas limited exposure to infection in this period of life increases the risk of disease by enhancing the possibility of abnormal immune response to infection acquired later.

The observation of temporary CL clusters in relatively isolated communities after increased entry of new individuals into these populations has provided support for the formulation of the \"population mixing\" hypothesis. Kinlen ^[@r27],[@r28]^ suggests that the introduction of a specific infectious agent in a non-immune population could cause an abnormal immune response to infection by this pathogen and cause a transient increase in leukemia cases.

This article reviews studies related to Smith and Greaves\' hypothesis on the role of infections and indirect measures of infection exposure on the risk of childhood leukemia, especially ALL.

METHODS
=======

In order to identify eligible studies published before January 3, 2012, a search was made in three scientific publication databases: Medline, ^[a](#fn01){ref-type="fn"}^ Lilacs ^[b](#fn02){ref-type="fn"}^ and SciELO. ^[c](#fn03){ref-type="fn"}^ Studies with subjects age ≤ 15 years old and specific analysis of cases diagnosed as ALL and/or total leukemia were included in this review. The search considered possible associated factors: maternal or infant exposure to infections or proxy of infections (day care attendance, birth order, breastfeeding, vaccination).

The descriptors used for searching in the Medline database were: infection and childhood leukemia. The preliminary list included 612 publications. We pre-selected articles by reading titles and abstracts and created a second list of 145 potentially eligible studies. The inclusion criteria were met in 47 of those 145 articles. The same descriptors were used to search in the SciELO and Lilacs databases. However, the term infection was replaced by infect\$. The use of \"\$\" symbol allows recording of words with the same root. The results included eight and fourteen studies, respectively. None met the inclusion criteria.

We looked for studies in the three databases using the descriptors \"childhood leukemia\", with the addition of words: infection or maternal disease, breastfeeding, day care, vaccination and birth order. We found a further 15 studies that met inclusion criteria and had not previously been screened.

RESULTS
=======

This review included 62 studies: 85.5% were case-control, 9.7% cohort and 4.8% ecological studies. The studies were conducted in Europe, North America, Asia, Africa, and Oceania and published between 1973 and 2011.

Direct assessment of exposure to infection in the mothers and children
----------------------------------------------------------------------

### Maternal infection

The association between maternal infection during pregnancy and CL was evaluated in 16 studies, and statistically significant increased risks of leukemia were detected in 11 ^[@r02],[@r08],[@r21],[@r33],[@r35],[@r36],[@r43],[@r47],[@r77],[@r78],[@r83]^ ([Table 1](#t01){ref-type="table"}). Associated infections were: influenza, pneumonia, chickenpox, herpes zoster, lower genital tract infection, skin disease, sexually transmitted diseases, Epstein-Barr virus (EBV), and *Helicobacter pylori* . Laboratory tests were performed for antibodies in maternal serum during pregnancy in three studies. ^[@r35],[@r36],[@r77]^ Maternal infection with EBV was associated with a significantly increased risk of ALL in two studies (odds ratio \[OR\] 2.9, 95% confidence interval \[95%CI\] 1.5;5.8; OR 1.9, 95%CI 1.2;3.0), ^[@r35],[@r77]^ and Lehtinen et al ^[@r36]^ found a high risk of CL (but not ALL) associated with *Helicobacter pylori* infection. Naumburg et al ^[@r47]^ identified a significantly increased risk of both ALL (OR 1.63, 95%CI 1.04;2.53) and CL (OR 1.78, 95%CI 1.17;2.72) associated with lower genital tract infections. Likewise, Kwan et al ^[@r33]^ showed that the risk of ALL and CL was increased in children whose mothers had influenza/pneumonia and sexually transmitted diseases during the pregnancy. No statistically significant association was found between maternal infection and leukemia in five studies. ^[@r12],[@r13],[@r24],[@r44],[@r59]^

###### 

Review of studies on maternal infection and risk of childhood leukemia, 1973-2011.

  Reference                                  Place                                 Study design      Infectious agent or disease     Disease                              Risk (95%CI)                                  
  ------------------------------------------ ------------------------------------- ----------------- ------------------------------- ------------------------------------ --------------------------------------------- ---------------------------------------------
  Increased risk                                                                                                                                                                                                        
                                             Hakulinen et al^[@r21]^(1973)         Finland           BC                              Asian influenza                      CL                                            Exposed incidence: 68.1/million
                                                                                                                                                                          Unexposed incidence: 4.2/million; P = 0.048   
                                             Austin et al^[@r02]^ (1975)           Los Angeles       BC                              Influenza                            CL                                            RR 3.4
                                             Vianna & Polan^[@r83]^ (1976)         USA               ECO                             Chicken pox                          CL                                            Expected incidence \< 1
                                                                                                                                                                          Observed incidence = 3                        
                                             Till et al^[@r78]^ (1979)             England           CC                              Varicella and herpes zoster          ALL                                           Number cases higher than expected (2 of 54)
                                             Mckinney et al^[@r43]^ (1987)         IREESC            CC                              Skin disease                         CL                                            RR 2.3 (1.1;4.7)
                                             Buckley et al^[@r08]^ (1994)          USA Canada        CC                              Any maternal infection               ALL                                           OR 1.5 (p \< 0.05)
                                             Naumburg et al^[@r47]^ (2002)         Sweden            CC                              Lower genital tract infection        ALL                                           OR 1.63 (1.04;2.53)
                                                                                                                                                                          CL                                            OR 1.78 (1.17;2.72)
                                             Lehtinen et al^[@r35]^ (2003)         Finland Iceland   CC                              *Epstein-Barr* virus                 ALL                                           OR 2.9 (1.5;5,8)
                                             Lehtinen et al^[@r36]^ (2005)         Finland Iceland   CC                              Helicobacter pylori                  CL                                            OR 2.8 (1.1;6.9)
                                             Kwan et al^[@r33]^ (2007)             California        CC                              Influenza/pneumonia                  ALL                                           OR 1.89 (1.24;2.89)
                                                                                                                                     CL                                   OR 1.74 (1.18;2.57)                           
                                                                                                     Sexually transmitted diseases   ALL                                  OR 4.85 (1.24;18.96)                          
                                                                                                                                     CL                                   OR 6.33 (1.65;24.27)                          
                                             Tedeschi et al^[@r77]^ (2007)         Finland Iceland   CC                              *Epstein-Barr* virus                 ALL                                           OR 1.9 (1.2;3.0)
  Non-significant effect or no association                                                                                                                                                                              
                                             Randolph & Heath^[@r59]^ (1974)       USA               BC                              Influenza                            CL                                            No consistent increased incidence
                                             Curnen et al^[@r12]^ (1974)           Connecticut       ECO                             Influenza, chickenpox, whooping...   CL                                            No significant positive correlations
                                             Dockerty et al^[@r13]^ (1999)         New Zealand       CC                              Influenza                            CL                                            OR 0.58 (0.24;1.41)
                                                                                                     Cold sores/oral herpes                                               OR 0.70 (0.25;1.99)                           
                                             Mckinney et al^[@r44]^ (1999)         Scotland          CC                              Respiratory tract                    ALL                                           OR 1.64 (0.60;4.46)
                                                                                                     Genitourinary                                                        OR 1.18 (0.50;2.79)                           
                                             Infante-Rivard et al^[@r24]^ (2000)   Quebec            CC                              Recurrent infections                 ALL                                           OR 1.09 (0.65;1.84)

BC: Birth cohort study; CC: Case-control study; ECO: Ecological study; CL: Childhood leukemia; ALL: Acute lymphoblastic leukemia; RR: Relative risk

### Childhood infection

[Table 2](#t02){ref-type="table"} shows twenty-three studies that evaluated the association between childhood infection and leukemia. Among those that analyzed infections in the first two years of life, five reported reduced risk of ALL associated with infection in the skin, ^[@r44]^ ears, ^[@r48],[@r81]^ or gastrointestinal tract, ^[@r25]^ and episodes of roseola and/or fever and rash. ^[@r10]^ Other two studies detected a higher risk of ALL in children with more frequent episodes of upper respiratory tract infection, ^[@r09],[@r64]^ fungal infection ^[@r64]^ and chickenpox. ^[@r09]^ A further five studies found reduced risk associated with some diseases and increased risk associated with others. ^[@r13],[@r52],[@r66],[@r67],[@r75]^ The association between common cold, fever, history of infection in the infant and leukemia was not significant in two studies. ^[@r47],[@r82]^

###### 

Review of studies on childhood infection and risk of leukemia, 1973-2011.

  Reference                                                                                Place                                                                       Study design     Infectious agent or disease   Disease                                                                           Risk (95%CI)    
  ---------------------------------------------------------------------------------------- --------------------------------------------------------------------------- ---------------- ----------------------------- --------------------------------------------------------------------------------- --------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------
  Infection in the first 2 years of life: protective effect                                                                                                                                                                                                                                                             
                                                                                           Dockerty et al^[@r13],[a](#tfn01t02){ref-type="table-fn"}^ (1999)           New Zealand      CC                            Eye infection                                                                     ALL             OR 0.2 (0.1;0.7)
                                                                                           Mckinney et al^[@r44]^ (1999)                                               Scotland         CC                            Skin infection                                                                    ALL             OR 0.2 (0.05;0.87)
                                                                                                                                                                                                                                                                                                        CL              OR 0.2 (0.05;0.87)
                                                                                           Neglia et al^[@r48]^ (2000)                                                 USA              CC                            Ear infection                                                                     ALL             Ear infection episodes reduced the risk: p trend = 0.026
                                                                                           Chan et al^[@r10],[a](#tfn01t02){ref-type="table-fn"}^ (2002)               Hong Kong        CC                            Roseola and/or fever + rash                                                       ALL             OR 0.33 (0.16;0.68)
                                                                                           Perrilat et al^[@r52],[a](#tfn01t02){ref-type="table-fn"}^ (2002)           France           CC                            Surgical procedures: ear, nose, throat                                            CL              OR 0.4 (0.2;0.9)
                                                                                           Jourdan-da Silva et al^[@r25],[a](#tfn01t02){ref-type="table-fn"}^ (2004)   France           CC                            ≥4 gastrointestinal infections                                                    ALL             OR 0.1 (0.03;0.6)
                                                                                           Rosembaum et al^[@r66],[a](#tfn01t02){ref-type="table-fn"}^ (2005)          New York State   CC                            Diarrhoea                                                                         ALL             OR 0.69 (0.48;0.99)
                                                                                           Simpson et al^[@r75],[a](#tfn01t02){ref-type="table-fn"}^ (2007)            UK               CC                            Eye infection                                                                     ALL             OR 0.7 (0.5;0.9)
                                                                                           Rudant et al^[@r67],[a](#tfn01t02){ref-type="table-fn"}^ (2010)             France           CC                            Otitis; Bronchiolitis/other lower respiratory tract infections; Gastroenteritis   ALL             OR 0.7 (0.5;1.0)
  OR 0.3 (0.2;0.6)                                                                                                                                                                                                                                                                                                      
  OR 0.3 (0.1;0.8)                                                                                                                                                                                                                                                                                                      
                                                                                           Urayama et al^[@r81]^ (2011)                                                California       CC                            Ear infection: non-Hispanic children; Hispanic children                           ALL             OR 0.39 (0.17;0.91)
  OR 0.48 (0.27;0.83)                                                                                                                                                                                                                                                                                                   
  Infection in the first 2 years of life: increased risk                                                                                                                                                                                                                                                                
                                                                                           Dockerty et al^[@r13],[a](#tfn01t02){ref-type="table-fn"}^ (1999)           New Zealand      CC                            Influenza                                                                         CL              OR 6.80 (1.81;25.66)
  ALL                                                                                      OR 6.0 (1.4;26.2)                                                                                                                                                                                                            
                                                                                           Perrilat et al^[@r52],[a](#tfn01t02){ref-type="table-fn"}^ (2002)           France           CC                            Mumps                                                                             CL              OR 3.2 (1.1;9.0)
                                                                                           Rosembaum et al^[@r66],[a](#tfn01t02){ref-type="table-fn"}^ (2005)          New York State   CC                            Otitis in the second year of life                                                 ALL B lineage   OR 1.56 (1.02;2.37)
                                                                                           Roman et al^[@r64]^ (2007)                                                  UK               CC                            Upper respiratory tract infection Fungal infection                                ALL             OR 1.3 (1.0;1.7)
  OR 1.9 (1.1;3.2)                                                                                                                                                                                                                                                                                                      
                                                                                           Simpson et al^[@r75],[a](#tfn01t02){ref-type="table-fn"}^ (2007)            UK               CC                            At least one infection                                                            ALL             OR 1.6 (1.1;2.2)
                                                                                           Cardwell et al^[@r09]^ (2008)                                               UK               CC                            Upper respiratory tract infections; Chickenpox                                    ALL             OR 1.59 (1.02;2.49)
  OR 2.62 (1.12;6.13)                                                                                                                                                                                                                                                                                                   
                                                                                           Rudant et al^[@r67],[a](#tfn01t02){ref-type="table-fn"}^ (2010)             France           CC                            Upper respiratory tract infections                                                ALL             OR 1.6 (1.3;2.0)
  Infection in the first 2 years of life: non-significant effects or no association                                                                                                                                                                                                                                     
                                                                                           Van Steensel-Moll et al^[@r82]^ (1986)                                      Netherlands      CC                            Common colds; Fever                                                               ALL             RR 0.8; p \> 0.05; RR 0.9; p \> 0.05
                                                                                           Naumburg et al^[@r47]^ (2002)                                               Sweden           CC                            History of infection in the postpartum                                            CL              OR 1.0 (0.50;2.04)
  Infection at any time prior to the diagnosis: protective effect                                                                                                                                                                                                                                                       
                                                                                           Schlehofer et al^[@r68],[a](#tfn01t02){ref-type="table-fn"}^ (1996)         Germany          CC                            Herpes labialis                                                                   CL              RR 0.38 (0.15;0.96)
                                                                                           Schuz et al^[@r70],[a](#tfn01t02){ref-type="table-fn"}^ (1999)              Germany          CC                            Chickenpox                                                                        AL              OR 0.8 (0.7;1.0)
                                                                                           Ma et al^[@r38]^ 2(005)                                                     California       CC                            Ear infection (in non-Hispanic)                                                   c-ALL           OR 0.32 (0.14;0.74)
  Infection at any time prior to the diagnosis: increased risk                                                                                                                                                                                                                                                          
                                                                                           Mckinney et al^[@r43]^ (1987)                                               UK               CC                            Number of illness episodes                                                        CL              RR 1.9 (1.0;3.4)
                                                                                           Jourdan-da Silva et al^[@r25],[a](#tfn01t02){ref-type="table-fn"}^ (2004)   France           CC                            Rubella                                                                           ALL             OR 2.4 (1.4;4.1)
  Infection at any time prior to the diagnosis: non-significant effect or no association                                                                                                                                                                                                                                
                                                                                           Macarthur et al^[@r40]^ (2008)                                              Canada           CC                            Mumps                                                                             ALL             OR 0.57 (0.13;2.52)
  Measles                                                                                  OR 0.62 (0.25;1.27)                                                                                                                                                                                                          
  Infection at diagnosis or in the year before diagnosis: increased risk                                                                                                                                                                                                                                                
                                                                                           Schuz et al^[@r70],[a](#tfn01t02){ref-type="table-fn"}^ (1999)              Germany          CC                            Bronchitis                                                                        c-ALL           OR 1.9 (1.3;2.7)
  Pneumonia                                                                                OR 2.6 (1.4;4.8)                                                                                                                                                                                                             
                                                                                           Chan et al^[@r10],[a](#tfn01t02){ref-type="table-fn"}^ (2002)               Hong Kong        CC                            Tonsillitis                                                                       c-ALL           OR 2.96 (1.32;6.66)
                                                                                           Kroll et al^[@r29]^ (2006)                                                  Britain          ECO                           Influenza                                                                         c-ALL           Influenza epidemic preceded peak of c-ALL
  Infection at diagnosis or in the year before diagnosis: laboratory analysis                                                                                                                                                                                                                                           
                                                                                           Schlehofer et al^[@r68],[a](#tfn01t02){ref-type="table-fn"}^ (1996)         Germany          CC                            Epstein-Barr Virus                                                                CL              RR 2.05 (0.99;4.23)
  Parvovirus B-19                                                                          RR 0.48 (0.14;1.69)                                                                                                                                                                                                          
  Adeno-associated virus type 2                                                            RR 0.66 (0.29;1.50)                                                                                                                                                                                                          
  Human herpes virus type 6.                                                               RR 1.11 (0.54;2.28)                                                                                                                                                                                                          
                                                                                           Petridou et al^[@r56]^ (2001)                                               Greece           CC                            Epstein-Barr virus                                                                ALL             OR 0.4 (0.2;0.8)
  Human herpes virus type 6                                                                OR 0.5 (0.3;0.9)                                                                                                                                                                                                             
  Mycoplasma                                                                               OR 0.1 (0.0;0.7)                                                                                                                                                                                                             
  Parainfluenza1,2,3                                                                       OR 1.9 (1.1;3.2)                                                                                                                                                                                                             
                                                                                           Mahjour et al^[@r41]^ (2010)                                                Iran             CC                            Herpes Simplex Viruses 1 and 2;                                                   ALL             The prevalence of antibodies against HBsAg (p = 0.002), HSV1 (p \< 0.0001), VCA (p = 0.021) and EA (p \< 0.0001) antigens of EBV were higher in ALL patients.
  Epstein-Barr Virus;                                                                                                                                                                                                                                                                                                   
  hepatitis B Virus                                                                                                                                                                                                                                                                                                     
                                                                                           Sehgal et al^[@r71]^ (2010)                                                 India            CC                            Epstein Barr Virus                                                                ALL             Significant increase in EBV in ALL patients (p \< 0.05)

CC: Case-control study; ECO: Ecological study; CL: Childhood leukemia; ALL: Acute lymphoblastic leukemia; AL: Acute leukemia; c-ALL: B-cell precursor common AL; RR: Relative risk; OR: Odds ratio; 95%CI: 95% confidence interval

Study listed more than once in the table

Exposure to infection at any time prior to diagnosis was examined in six studies. ^[@r25],[@r38],[@r40],[@r43],[@r68],[@r70]^ A protective effect against leukemia in children with herpes labialis, ^[@r68]^ chickenpox, ^[@r70]^ and ear infection was detected. ^[@r38]^ Mckinney et al ^[@r43]^ and Jourdan-Da Silva et al, ^[@r25]^ respectively, identified an increased risk of leukemia correlating with total number of illness and rubella episodes. Macarthur et al ^[@r40]^ found a reduced risk of ALL in children with mumps or measles, but the results were not precise.

The occurrence of infection at leukemia diagnosis or in the year before diagnosis was evaluated in seven studies. ^[@r10],[@r29],[@r41],[@r56],[@r68],[@r70],[@r71]^ Among those, four performed laboratory tests to investigate exposure to specific infections. Petridou et al ^[@r56]^ found a lower risk of ALL associated with EBV, human herpes virus 6 (HHV6), and mycoplasma exposure, and increased risk associated with parainfluenza. Other two studies ^[@r41],[@r71]^ identified increased risk of ALL in children exposed to the herpes simplex virus 1 and 2, hepatitis B virus, and EBV. Schlehofer et al ^[@r68]^ found no significant association between EBV infection, HHV6, parvovirus B19, or the adeno-associated virus and ALL.

Indirect assessment of exposure to infections in childhood
==========================================================

Daycare attendance
------------------

[Table 3](#t03){ref-type="table"} presents information on studies that investigated the association between daycare attendance and leukemia. Nine studies identified a statistically significant reduced risk of leukemia related to daycare attendance. ^[@r15],[@r24]-[@r26],[@r37],[@r38],[@r52],[@r54],[@r81]^ Perrilat et al ^[@r52]^ and Gilham et al ^[@r15]^ detected a more pronounced protective effect for children having started daycare in early life (OR 0.5, 95%CI 0.3;1.0 for age ≤ 6 months; OR 0.56, 95%CI 0.37;0.83 for age \< 3 months) than in those having started daycare at older ages, but the trend for age of starting daycare was not statistically significant. In Jourdan-Da Silva et al, ^[@r25]^ a statistically significant association was only observed when daycare started before 3 months old (OR 0.6, 95%CI 0.4;0.8) and the trend was also statistically significant (p trend \< 0.05).

###### 

Review of studies on daycare attendance and risk of childhood

  Reference                                                   Place                                   Study design      Disease   Variables   Risk (95%CI)                                                                
  ----------------------------------------------------------- --------------------------------------- ----------------- --------- ----------- --------------------------------------------------------------------------- ---------------------
  Protective effect                                                                                                                                                                                                       
                                                              Petridou et al^[@r54]^ (1993)           Attica (Greece)   CC        CL          Attendance at day-care for \> 3 months in the first two years of life       OR 0.28 (0.09;0.88)
                                                              Infante-Rivard et al^[@r24]^ (2000)     Quebec            CC        ALL         Entry at ≤ 2 years old                                                      OR 0.49 (0.31;0.77)
                                                              Perrilat et al^[@r52]^ (2002)           France            CC        AL          Age at start of day care ≤ 6 months *versus* no day-care                    OR 0.5 (0.3;1.0)
                                                              Ma et al^[@r37]^ (2002)                 California        CC        ALL         Children who had more total child -- hours of attendance at day-care        OR 0.64 (0.45;0.95)
                                                              Jourdan-Da Silva et al^[@r25]^ (2004)   France            CC        ALL         Age at start of day-care \< 3 months *versus* no day-care                   OR 0.6 (0.4;0.8)
                                                              Ma et al^[@r38]^ (2005)                 California        CC        ALL         Children (non-Hispanic white) who had more time of attendance at day-care   OR 0.42 (0.18;0.99)
                                                              Gilham et al^[@r15]^ (2005)             UK                CC        ALL         Formal day care in the first year of life                                   OR 0.48 (0.37;0.62)
  Age at start of day-care \< 3 months *versus* no day-care   OR 0.56 (0.37;0.83)                                                                                                                                         
                                                              Kamper-Jorgensen et al^[@r26]^ (2008)   Denmark           CC        ALL         Childcare in the first 2 years                                              OR 0.68 (0.48;0.95)
                                                              Urayama^[@r81]^ (2011)                  California        CC        ALL         Attendance day-care by age 6 months (non-Hispanic white)                    OR 0.83 (0.73;0.94)
  Non-significant effect or no association                                                                                                                                                                                
                                                              Roman et al^[@r63]^ (1994)              England           CC        ALL         Child\'s attendance at preschool playgroup                                  OR 0.6 (0.2;1.8)
                                                              Petridou et al^[@r55]^ (1997)           Greece            CC        CL          Day-care: Yes *versus* No                                                   OR 0.83 (0.51;1.37)
                                                              Schuz et al^[@r70]^ (1999)              Germany           CC        c-ALL       Deficit in social contact                                                   OR 1.0 (0.8;1.2)
                                                              Neglia et al^[@r48]^ (2000)             USA               CC        ALL         Age at start of day care \< 6 months                                        OR 0.91 (0.72;1.15)
                                                              Rosenbaum et al^[@r65]^ (2000)          New York State    CC        ALL         Duration of out-of-home care (months): stayed home (*versus* \> 36)         OR 1.32 (0.70;2.52)
                                                              Chan et al^[@r10]^ (2002)               Hong Kong         CC        c-ALL       Attendance at day-care during first year of life                            OR 0.93 (0.63;1.36)
                                                              Abdul Rahman et al^[@r01]^ (2008)       Malaysia          CC        AL          Attendance in day-care (Yes *versus* No)                                    OR 1.12 (0.65;1.92)
                                                              Rudant et al^[@r67]^ (2010)             France            CC        ALL         Full-time day-care attendance in the first year of life                     OR 0.8 (0.6;1.1)

CC: Case-control study; CL: Childhood leukemia; ALL: Acute lymphoblastic leukemia; AL: Acute leukemia; c-ALL: B-cell precursor common ALL; OR: Odds ratio; 95%CI: 95% confidence interval

In other eight studies no statistically significant association or effects were reported. ^[@r01],[@r10],[@r48],[@r55],[@r63],[@r65],[@r67],[@r70]^ Neglia et al ^[@r48]^ did not find association even when the daycare began before 6 months of age.

Birth order
-----------

The relationship between birth order and leukemia was evaluated in 21 studies ([Table 4](#t04){ref-type="table"}). Van Steensel-Moll ^[@r82]^ detected increased ALL risk in children with lower birth order (first-born). Four studies found a protective effect associated with higher birth order. ^[@r14],[@r56],[@r67],[@r81]^ Of these, Dockerty et al ^[@r14]^ observed ALL risk reduction with increased parity (p trend \< 0.001) in a sample of 2,942 cases and the same number of controls in England and Wales.

###### 

Review of studies on birth order and risk of childhood leukemia, 1973-2011.

  Reference                                                                                                                      Place                                                                     Study design    Disease   Variables   Risk (95%CI)                                                                                      
  ------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------- --------------- --------- ----------- ------------------------------------------------------------------------------------------------- ----------------------
  Negative association: protective effect associated with higher birth order/ increased risk associated with lower birth order                                                                                                                                                                                                                     
                                                                                                                                 Van steensel-moll^[@r82]^ (1986)                                          Netherlands     CC        ALL         There were more first-born children in cases                                                      RR 1.8 (1.1;2.7)
                                                                                                                                 Infante-Rivard et al^[@r24],[a](#tfn01t04){ref-type="table-fn"}^ (2000)   Quebec          CC        ALL         Having older siblings in the 1^st^ year of life (in cases diagnosed at 4 years of age or later)   OR 0.46 (0.22;0.97)
                                                                                                                                 Petridou et al^[@r56]^ (2001)                                             Greece          CC        ALL         Birth order: other *versus* first                                                                 OR 0.5 (0.3;0.9)
                                                                                                                                 Dockerty et al^[@r14]^ (2001)                                             England Wales   CC        ALL         Parity ≥ 5                                                                                        OR 0.52 (0.34;0.80)
                                                                                                                                 Rudant et al^[@r67]^ (2010)                                               France          CC        ALL         Parity ≥ 4 *versus* 1                                                                             OR 0.5 (0.3;0.8)
                                                                                                                                 Urayama^[@r81]^ (2011)                                                    California      CC        ALL         Birth order ≥ 4 *versus* 1(in children non-Hispanic white)                                        OR 0.44 (0.21;0.92)
  Positive association: increased risk associated with higher birth order/ protective effect associated with lower birth order                                                                                                                                                                                                                     
                                                                                                                                 Infante-Rivard et al^[@r24],[a](#tfn01t04){ref-type="table-fn"}^ (2000)   Quebec          CC        ALL         Having older siblings at time of diagnosis (in children diagnosed before 4 years of age)          OR 4.54 (2.27;9.07)
                                                                                                                                 Shu et al^[@r73]^ (2002)                                                  USA             CC        ALL         Birth order ≥ 4 *versus* 1                                                                        OR 2.0 (1.3;3.0)
                                                                                                                                 Reynolds et al^[@r61]^ (2002)                                             California      CC        ALL         Number of previous live births ≥ 3 *versus* 0 (in children aged \< 2 years)                       OR 1.53 (1.00;2.34)
                                                                                                                                 Jourdan-Da Silva et al^[@r25]^ (2004)                                     France          CC        ALL         Birth order ≥ 4 *versus* 1                                                                        OR 2.0 (1.1;3.7)
                                                                                                                                 Abdul Rahman et al^[@r01]^ (2008)                                         Malaysia        CC        AL          Number of elder siblings \< 2 *versus* ≥ 2                                                        OR 0.37 (0.22;0.64)
  Non-significant effect or no association                                                                                                                                                                                                                                                                                                         
                                                                                                                                 Roman et al^[@r63]^ (1994)                                                England         CC        ALL         Number of siblings ≥ 2 *versus* 0                                                                 OR 0.8 (0.2;3.0)
                                                                                                                                 Westergaard et al^[@r85]^ (1997)                                          Denmark         COH       ALL         Birth order ≥ 4 *versus* 1                                                                        RR 0.72 (0.46;1.13)
                                                                                                                                 Petridou et al^[@r55]^ (1997)                                             Greece          CC        CL          Risk decreases with increasing birth order                                                        OR 0.74 (0.48;1.15)
                                                                                                                                 Schuz et al^[@r70]^ (1999)                                                German          CC        c-ALL       First-born child (yes *versus* no)                                                                OR 1.1 (1.0;1.4)
                                                                                                                                 Mckinney et al^[@r44]^ (1999)                                             Scotland        CC        ALL         Parity (0 *versus* 1 or more)                                                                     OR 0.81 (0.52;1.25)
                                                                                                                                                                                                                                     CL                                                                                                            OR 0.82 (0.55;1.23)
                                                                                                                                 Neglia et al^[@r48]^ (2000)                                               USA             CC        ALL         Number of older siblings ≥ 2 *versus* 0                                                           OR 1.05 (0.88;1.26)
                                                                                                                                 Perrilat et al^[@r52]^ (2002)                                             France          CC        ALL         Birth order ≥ 4 *versus* 1                                                                        OR 1.4 (0.7;2.8)
                                                                                                                                 Murray et al^[@r46]^ (2002)                                               Ireland         COH       ALL         First-born *versus* Not first born                                                                RR 0.98 (0.71;1.36)
                                                                                                                                 Okcu et al^[@r50]^ (2002)                                                 Texas           CC        ALL         Parity ≥ 5 *versus* 0                                                                             OR 1.0 (0.1;7.8)
                                                                                                                                                                                                                                     CL                                                                                                            OR 0.5 (0.1;4.3)
                                                                                                                                 Gilham et al^[@r15]^ (2005)                                               UK              CC        ALL         Number of siblings ≥ 3 *versus* none                                                              OR 0.99 (0.74;1.30)
                                                                                                                                 Kamper-Jorgensen et al^[@r26]^ (2008)                                     Denmark         CC        ALL         Older siblings \> 2 *versus* 0                                                                    RR 0.93 (0.72; 1.19)

CC: Case-control study; COH: Cohort study; CL: Childhood leukemia; ALL: Acute lymphoblastic leukemia; AL: Acute leukemia; c-ALL: B-cell precursor common ALL; RR: Relative risk; OR: Odds ratio; 95%CI: 95% confidence interval

Study listed more than once in the table

Infante-Rivard et al ^[@r24]^ detected a reduced ALL risk in children aged four and over who had at least one older sibling in the first year of life (OR 0.46, 95%CI 0.22;0.97), but they observed a higher ALL risk in children under four years old who had at least one older sibling at diagnosis (OR 4.54, 95%CI 2.27;9.07).

Three studies found higher ALL risk related to higher birth order. ^[@r25],[@r61],[@r73]^ Shu et al ^[@r73]^ in the United States (1,842 cases of ALL, 1,986 controls) detected positive association (OR 2.0, 95%CI 1.3;3.0; p trend \< 0.01). Abdul Rahman et al ^[@r01]^ identified reduced risk of acute leukemia related to lower birth order.

However, 11 studies showed no statistically significant association. ^[@r15],[@r26],[@r44],[@r46],[@r48],[@r50],[@r52],[@r55],[@r63],[@r70],[@r85]^ Westergaard et al, ^[@r85]^ in a cohort study in Denmark, found a reduced risk of ALL related to higher birth order, but the result was not precise (relative risk \[RR\] 0.72, 95%CI 0.46;1.13).

Assessment of child immune status
=================================

Breastfeeding
-------------

[Table 5](#t05){ref-type="table"} lists the studies that investigated the association between leukemia and breastfeeding. A protective effect in children with more breastfeeding time was detected in five of those 17 studies. ^[@r13],[@r24],[@r53],[@r67],[@r72]^ Shu et al ^[@r72]^ identified a reducing ALL risk with increased breastfeeding time (p trend 0.003). Children who were breastfed for more than six months had a lower risk of ALL (OR 0.72, 95%CI 0.60;0.87) than those who were never breastfed. Two studies found a higher ALL risk in children breastfed for less than six months. ^[@r06],[@r07]^

###### 

Review of studies on breastfeeding and risk of childhood leukemia, 1973-2011.

  Reference                                                                                                                                         Place or group                          Study design             Disease   Time of breast feeding   Risk (95%CI)                              
  ------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------- ------------------------ --------- ------------------------ ----------------------------------------- ----------------------------
  Negative association: protective effect associated with longer breastfeeding period/increased risk associated with shorter breastfeeding period                                                                                                                                                 
                                                                                                                                                    Dockerty et al^[@r13]^ (1999)           New Zealand              CC        ALL                      \> 1 year                                 OR 0.5 (p = 0.04)
                                                                                                                                                    Shu et al^[@r72]^ (1999)                USA, Canada, Australia   CC        ALL                      \> 6 *versus* 0                           OR 0.72 (0.60;0.87)
                                                                                                                                                                                                                                                        More time breastfeeding                   p trend = 0.0034
                                                                                                                                                    Infante-Rivard et al^[@r24]^ (2000)     Quebec                   CC        ALL                      \>3 months *versus* 0                     OR 0.67 (0.47;0.94)
                                                                                                                                                    Bener et al^[@r06]^ (2001)              United Arab Emirates     CC        ALL                      0-6 months *versus* \> 6                  OR 2.47 (1.17;5.25)
                                                                                                                                                    Perrilat et al^[@r53]^ (2002)           France                   CC        AL                       ≥ 6 months *versus* 0                     OR 0.5 (0.2;0.9)
                                                                                                                                                    Bener et al^[@r07]^ (2008)              Qatar                    CC        ALL                      0-6 months *versus* \> 6                  Males: OR 3.1 (1.4;6.8)
                                                                                                                                                                                                                                                                                                  Females: OR 2.2 (0.8;6.32)
                                                                                                                                                    Rudant et al^[@r67]^ (2010)             France                   CC        ALL                      ≥ 6 months *versus* \> 0                  OR 0.7 (0.5;1.0)
  Non-significant effect or no association                                                                                                                                                                                                                                                        
                                                                                                                                                    Petridou et al^[@r55]^ (1997)           Greece                   CC        CL                       yes *versus* no                           OR 0.85 (0.52;1.41)
                                                                                                                                                    Schuz et al^[@r70]^ (1999)              Germany                  CC        c-ALL                    2-6 months *versus* \> 6                  OR 1.2 (0.9;1.6)
                                                                                                                                                    UKCCS^[@r79]^ (2001)                    UK                       CC        ALL                      ≥ 7 months *versus* 0                     OR 0.89 (0.75;1.05)
                                                                                                                                                    Murray et al^[@r46]^ (2002)             Ireland                  COH       ALL                      no *versus* yes                           RR 0.98 (0.68;1.42)
                                                                                                                                                    Chan et al^[@r10]^ (2002)               Hong Kong                CC        c-ALL                    ≥ 6 months (yes *versus* no)              OR 0.21 (0.03;1.76)
                                                                                                                                                    Lancashire & Sorahan^[@r34]^ (2003)     UK                       CC        ALL                      ever *versus* never                       OR 1.04 (0.86;1.26)
                                                                                                                                                                                                                               CL                                                                 OR 1.05 (0.89 ;1.23)
                                                                                                                                                    Jourdan-Da Silva et al^[@r25]^ (2004)   France                   CC        ALL                      yes *versus* no                           OR 1.1 (0.9;1.5)
                                                                                                                                                    Kwan et al^[@r32]^ (2005)               California               CC        ALL                      ever *versus* never                       OR 0.99 (0.64;1.55)
                                                                                                                                                    Macarthur et al^[@r40]^ (2008)          Canada                   CC        ALL                      7-12 months (yes *versus* no)             OR 1.02 (0.68;1.53)
                                                                                                                                                                                                                               CL                                                                 OR 1.00 (0.67;1.50)
                                                                                                                                                    Waly et al^[@r84]^ (2011)               Oman                     CC        ALL                      No statistically significant difference   χ2 = 3.816, P = 0.282

CC: Case-control study; COH: Cohort study; CL: Childhood leukemia; ALL: Acute lymphoblastic leukemia; AL: Acute leukemia; c-ALL: B-cell precursor common ALL; RR: Risk relative; OR: Odds ratio; 95%CI: 95% confidence interval

Ten studies found no association between breastfeeding and CL. ^[@r10],[@r25],[@r32],[@r34],[@r40],[@r46],[@r55],[@r70],[@r79],[@r84]^ In a large study (1,342 CL cases) conducted in the United Kingdom, no association was seen with breastfeeding duration (p trend 0.90). ^[@r34]^

Vaccination
-----------

Eleven studies explored associations between vaccination and leukemia (data not shown). ^[@r03],[@r08],[@r13],[@r20],[@r39],[@r40],[@r42],[@r43],[@r49],[@r55],[@r70]^ Five of these identified a reduced risk in children who were vaccinated (any vaccine) ^[@r13],[@r43]^ or who had been immunized with BCG ^[@r49]^ and Hib (*Haemophilus influenzae* type B) ^[@r20],[@r39]^ vaccine. Ma et al ^[@r39]^ detected a lower risk of ALL (OR 0.81, 95%CI 0.66;0.98) and CL (OR 0.81, 95%CI 0.68;0.96) associated with the Hib vaccine. Furthermore, Schuz et al ^[@r70]^ observed an increased c-ALL risk in children who had received less than four vaccines compared to those who had received six or more.

On the other hand, Buckley et al ^[@r08]^ found an increased risk of c-ALL (OR 1.7, p \< 0.01) in children who received the MMR (measles, mumps and rubella) vaccine. Four studies found no statistically significant association between these variables. ^[@r03],[@r40],[@r42],[@r55]^

DISCUSSION
==========

Greaves ^[@r17],[@r19]^ argues that infections play an important role in the natural history of ALL, and especially c-ALL, considering the two hit model involving two independent genetic mutations. The first event concerns the initial genetic damage which occurs in the uterus during B cell precursor expansion producing a pre-leukemic clone. The second concerns postnatal genetic mutation that can lead to disease development.

According to this review, more than 50.0% of studies investigating maternal exposure to infection observed increasing risk of CL. These results support the hypothesis proposed by Smith. ^[@r76]^ It is possible that exposure to *in utero* infection is one of the factors involved in genetic damage in the first \"hit\" referred to by Greaves. ^[@r17]^

Results of childhood exposure to infections support the hypothesis that infection early in life (especially the first year of life) is associated with reduced risk of ALL. Even so, data are conflicting. Some factors may contribute to the apparent inconsistency between studies. ^[d](#fn04){ref-type="fn"}^ First, infections may only be involved in the etiology of a specific subtype of ALL (most probably c-ALL). For this reason, recent studies have analyzed all cases of ALL and specifically c-ALL. Another difficulty concerns when the infections occurred. Studies evaluating infection occurrence at any time prior to diagnosis showed more inconsistent results. Future studies should evaluate the infection occurrence in specific periods such as the first year and one year before diagnosis. In this way, data would help assess whether a lack of immune system modulation in early childhood, associated with a delay in infection occurrence, increases the risk of ALL. In relation to the display window, infections detected near the leukemia diagnosis may be due to an increased susceptibility to infections resulting from the effects of leukemia itself. Some protocols exclude data on infections occurring in the three months before diagnosis date to avoid bias.

The instrument used to directly assess exposure to infection is another limitation we found. Most studies used data from mothers via questionnaires for the recall of infection occurrence. This method is subject to misclassification bias, with differential recall between cases and controls. Only three of the studies in this review obtained clinical records to evaluate children\'s exposure to infection. ^[@r09],[@r64],[@r75]^ Although this latter method is not affected by recall bias, it does present other difficulties. The lack of a clinical records system with extensive population coverage and good quality data hinders the use of this instrument. Furthermore, the number of infections can be underestimated because the occurrence of common infections does not always mean that the mother seeks health service help. Simpson et al ^[@r75]^ compared results from clinical diagnoses of infection with those based on maternal self-report. They observed that mothers of cases and controls under-reported the frequency of infections in the first year of life. However, the degree of under-reporting appeared greater for mothers of cases than of controls.

Chang et al ^[@r11]^ used records of medically diagnosed infections and they found higher risk of ALL in children who had had acute respiratory infections and any infections before 1 year of age. The authors suggest that children who develop leukemia may have dysregulated immune function since early childhood strongly reacting to infections.

However, they do not refute the \"delayed infection hypothesis\" supported by several studies using proxy measures and state that their results are not relevant to asymptomatic infections or infections not requiring medical attention.

The difficulty in measuring the occurrence of infectious diseases in childhood leads epidemiologists to use proxy measures of exposure to infection: indirect measures that indicate levels of physical and social contact. These variables are easier to obtain, are less prone to recall bias, and probably include children with asymptomatic infections.

Daycare attendance has been widely used as an indicator of a child\'s level of social contact and therefore opportunity of contact with infectious agents. Interaction between children, parents, and staff, and the sharing of toys are factors that may contribute to increased transmission of infectious agents. Exposure to respiratory and gastrointestinal tracts infections are known to be more frequent in this type of environment. ^[@r23],[@r51]^ In general, the studies in our review show evidence supporting a reduced risk of ALL associated with daycare attendance, providing support to the hypothesis proposed by Greaves. In a meta-analysis, Urayama et al ^[@r80]^ found a reduced risk of ALL in two subgroups of children -- those who attended day-care before two years of age and those where age at day-care attendance was not specified (any age before diagnosis).

Birth order has also been used as a proxy variable for infection since children with older siblings are more likely to be exposed to infection due to contact with their siblings. ^[d](#fn04){ref-type="fn"}^ Most studies showed no evidence of an association between these variables. Parity is probably influenced by selection bias. Couples with higher socioeconomic status (SES) tend to have fewer children so there may be some confounding effect if SES is assessed differently between groups (cases and controls). Moreover, Edgar & Morgan ^[d](#fn04){ref-type="fn"}^ report that studies generally do not differentiate between the firstborn and the only child. Then, the association of ALL with a history of abortion and reproductive failures may be a confounding factor.

The association between SES and CL has been discussed in the literature. SES does influence the level of exposure and vulnerability of individuals to certain diseases. However, some studies have shown that increased risk of CL seems to be associated with increased SES. ^[@r30],[@r62]^ In Sao Paulo, Southwestern Brazil, Ribeiro et al ^[@r62]^ found a lower risk of leukemia in children living in areas with lower SES and in areas where a high percentage of families had more than seven members. However, in the review conducted by Poole et al, ^[@r58]^ the association direction seems to vary according to study design, place and time; they also highlighted comparison difficulties between studies because of differences in assessing SES. Measures such as family income and parental education presented an inverse association. Evaluation considering professional class revealed increased CL risk associated with higher SES in both ecological and individual approach studies.

Breast milk protects the child against infections and boosts the immune system contributing to its modulation. ^[@r22]^ It is therefore reasonable to assume that breastfeeding exerts a similar effect to early infection on a child\'s immunity inducing a protective effect against leukemia. ^[d](#fn04){ref-type="fn"}^ Most of the studies in our review did not identify a statistically significant association between ALL and breastfeeding duration. However, in a meta-analysis including 14 studies, Kwan et al ^[@r31]^ identified a protective effect from breastfeeding on ALL.

While not an actual infection, vaccine acts on the immune system as an infection does. ^[d](#fn04){ref-type="fn"}^ Results from the reviewed studies have provided some evidence of a protective effect from vaccination on the risk of ALL, especially regarding the Hib vaccine. One major difficulty with this variable is that high vaccination coverage makes it difficult to gauge the effect on CL. ^[d](#fn04){ref-type="fn"}^

Although no specific etiological agent has been identified, results of the studies reviewed provide evidence that the lack of exposure to infections during early childhood, and consequent failure in modulation of the immune system, may increase the risk of developing leukemia by the occurrence of an abnormal immune response after exposure to a later infection, as reported by Greaves. ^[@r17],[@r18]^ However, the mechanisms involved in this process are still not completely clear.

Schmiegelow et al ^[@r69]^ proposed in 2008 an explanation for the observed association between infections in early childhood and reduced risk of ALL: the adrenal hypothesis. This postulates that children with lower SES, thus subject to getting infections more often, have a lower risk of ALL, because changes in the hypothalamic-pituitary-adrenal axis induced by infection lead to increased cortisol plasma levels similar to those observed during antileukemic therapy, leading to pre-leukemic cell apoptosis. Furthermore, the immune system can adapt to high infectious loads preventing a more reactive inflammatory response induced by Th1 cytokines in that cortisol favors the production of anti-inflammatory Th2 cytokines. Azevedo-Silva et al ^[@r04]^ show differences in ALL incidence rates across Brazilian regions. Salvador and Aracaju, cities in the Northeast, had the lowest rates, while Curitiba, Southeast, and Goiania, Midwest, had the highest. Brazilian regions show very distinct social and economic profiles. These authors suggest that the differences in incidence rates could be due to an early exposure to infectious agents in children living in areas with characteristics favoring the continued exposure to such agents. The lower ALL incidence rates in children from those cities (less developed) would then support the adrenal hypothesis.

Besides the lack of immune system modulation, WIEMELS ^[@r86]^ reports another phenomenon that would leads to an increased risk of CL: children with dysregulated immune function at birth are at higher risk for developing leukemia due to constitutively lower expression of IL-10, a cytokine that is critical in preventing an overactive inflammatory response to pathogenic infections. This factor would explain why in some studies ^[@r11]^ children with ALL had significantly more clinically diagnosed infectious episodes in the first year of life compared to controls.

The purpose of this study was to review epidemiological studies related to two hypotheses which propose a role for infections in CL etiology. Considering the \"two hit\" model by Greaves, ^[@r17]^ it is possible that the Smith hypothesis may play a role in the first hit and delayed infection in the second. Overall, this review provides evidence supporting the role of infections in the natural history of CL. This justifies further research even though no specific infectious agent has so far been associated with the disease. With regard to assessing exposure to infection or modulation of the immune system using a proxy, results were more consistent using daycare attendance than birth order, breastfeeding, or vaccination. Future studies should consider carefully evaluating exposure to infection at different stages of childhood. Accurate data on exposure period (in early childhood or near diagnosis), especially in relation to daycare attendance and the occurrence of infection episodes, are essential in eliminating potential bias and improving study accuracy. Furthermore, different subtypes of the disease require specific analysis because infectious agents can have distinct roles in the etiology of each subtype. Specific attention to these points, in addition to the contribution from genetic studies, is essential to help clarify the relationship between infections and CL etiology.
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